Combined behavioral treatment for nighttime urination and poor sleep in older adults
Tests a combined behavioral program for nocturia and insomnia in older adults.
Key facts
- Who runs it
- Atlanta VA Medical Center
- Where
- Atlanta and Los Angeles, United StatesSee the 2 sites
- Trial code
- Registry title
- Multi-center Trial to Improve Nocturia and Sleep in Older Adults
- Status
- Recruiting
- People taking part
- 192 people, planned
- Started
- 5 Dec 2023
- Expected to end
- Aug 2028
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Integrated Behavioral Therapy Program
- Health Education Program
- Record updated
- 13 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 60 or older who wake at night to urinate (nocturia) and also have insomnia. It tests a combined behavioral therapy program.
- Age
- 60 years or older
- Sex
- All sexes
- Disease stage
- On average 2 or more night-time urination episodes per night on the ICIQ-OAB questionnaire, and an Insomnia Severity Index score above 7.
- Earlier treatment
- Cannot join after earlier cognitive behavioral therapy for insomnia, or earlier or current intensive behavioral therapy for insomnia or urinary symptoms. No new or stopped insomnia medicine in the past month. Bladder medicine doses must be stable.
Main reasons for not taking part
- Bipolar disorder, unstable psychiatric conditions, or a Mini-Mental State Exam score below 20
- Another sleep disorder that better explains the sleep problems, or untreated sleep-disordered breathing
- Current urinary tract infection, blood in the urine, or urine left in the bladder of 200 mL or more
- Unstable health conditions, such as poorly controlled heart failure, hemoglobin A1c of 9.0 or more, or chronic kidney disease stage 4 or 5
- Genitourinary cancer in active treatment, pelvic or colon surgery, or onabotulinum toxin for urinary symptoms within 6 months
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Age ≥ 60 years
- Average of ≥ 2 episodes per night of nocturia on the International Consultation on Incontinence Questionnaire-Overactive Bladder Module (ICIQ-OAB) questionnaire
- Insomnia Severity Index > 7
- Able to attend weekly study visits
Who cannot take part
- Prior cognitive behavioral therapy for insomnia
- Unstable doses or recent changes in bladder medication
- New or recently discontinued insomnia medication within past month
- Previous or current intensive behavioral therapy for insomnia or urinary symptoms,
- Pelvic or colon surgery within 6 months of enrollment or onabotulinum toxin therapy for urinary symptoms within 6 months of enrollment
- Presence of bipolar disorder
- Significant cognitive impairment as measured by a score < 20 on the Mini-Mental State Exam
- Sleep disturbance better explained by another sleep disorder such as restless legs syndrome, narcolepsy, insufficient sleep syndrome, or circadian rhythm sleep-wake disorders
- Current urinary tract infection or hematuria
- Unstable health conditions expected to result in death or hospitalization within 3 months, as assessed by overall study PIs or Site PI
- Unstable psychiatric conditions (e.g., psychosis, active alcohol/substance abuse based on history and medical records)
- Genitourinary cancer undergoing active treatment
- Unstable medical conditions that could contribute to nocturia or insomnia such as poorly controlled heart failure as evidenced on physical examination, poorly controlled diabetes mellitus with either hemoglobin A1c of ≥ 9.0, or chronic kidney disease (stage 4 or 5) or a potential to initiate dialysis in 3 months
- Untreated sleep-disordered breathing (respiratory event index ≥ 15 plus • Epworth Sleepiness Scale > 10 or respiratory event index > 30. Note that participants with treated sleep-disordered breathing will not be excluded)
- Unstable housing situation
- Evidence of significant urinary retention as measured by a residual bladder volume of ≥ 200 mL by bladder ultrasound with 15 minutes of voiding
Where in United States
- Atlanta VAHCSAtlanta, United StatesContact: E Camille Vaughan, MD, MSTaking people
- VA Greater Los Angeles Healthcare SystemLos Angeles, United StatesContact: Erin E Der-McleodTaking people
About the trial
What the trial wants to find out
The Multi-center Trial to Improve Nocturia and Sleep in Older Adults (MINT) study is a randomized trial to determine and assess the efficacy of integrated treatment of coexisting nocturia and insomnia, as well as explore the effects of this treatment on quality of life.
The 2 groups in the trial
- Integrated Behavioral Therapy ProgramTreatment being tested
Integrated Behavioral Therapy consists of 5 weekly one-hour sessions (face-to-face either through video or in-person) + 2 telephone check-in with an interventionist. This program integrates cognitive-behavioral treatment for nocturia and insomnia. Brief telephone check-ins will be comprised of review of topics discussed during the sessions.
- Health Education ProgramPlacebo, for comparison
The Health Education Program consists of 5 weekly one-hour sessions (face-to-face either through video or in-person) + 2 telephone check-in with an interventionist. The program modules focus on brain health and includes topics such physical activity, social engagement, sleep topics (e.g., changes in sleep that occur with aging, effects of poor sleep on health), medications/medical conditions, vision and hearing impairment. Brief telephone check-ins will be comprised of review of health topics discussed during the sessions.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Multi-center Trial to Improve Nocturia and Sleep in Older Adults (MINT)
- Plain-language title
- Combined behavioral treatment for nighttime urination and poor sleep in older adultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Publications
- An integrated behavioral treatment for improving nocturia and insomnia symptoms in older adults (MINT): study protocol for a multi-site randomized clinical trial.Trials, 2026
- Protocol for a multi-site randomized trial testing an integrated behavioral treatment for improving nocturia and insomnia symptoms in older adults (MINT).Research square, 2025
- Record updated
- 13 August 2026